discount discount.....ResearchAarkstore Enterprise Companion     Diagnostics in Personalized Medicine and Cancer     Thera...
1.1 Statement of Report 91.2 About This Report 91.3 Scope of the Report 101.4 Objectives 111.5 Methodology 111.6 Executive...
2.9.8 Abbott’s Late-Stage NSCLC Treatment, Xalkori (crizotinib) 472.10 Diagnostic Tests for Personalized Analysis of Cance...
Breast Cancer Therapies Markets HIV-AIDS Testing Markets Over-the-Counter Diagnostic Products World Markets DNA Sequencing...
Nuclear Cardiology MarketsMedical Imaging BundleCancer Vaccines MarketsEuropean Medical Imaging MarketsRespiratory Therape...
Upcoming SlideShare
Loading in...5
×

Discount discount.....research aarkstore enterprise companion diagnostics in personalized medicine and cancer therapy

101

Published on

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
101
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
2
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Discount discount.....research aarkstore enterprise companion diagnostics in personalized medicine and cancer therapy

  1. 1. discount discount.....ResearchAarkstore Enterprise Companion Diagnostics in Personalized Medicine and Cancer Therapyhttp://www.aarkstore.com/search/viewresults.asp?search=2012&PubId=&pagenum=1http://www.aarkstore.com/search/viewresults.asp?search=Markets&PubId=&pagenum=1http://www.aarkstore.com/search/viewresults.asp?search=Cancer%20&PubId=&pagenum=1Companion diagnostics (CDx) refers to a particular clinical diagnostic test that is underevaluation and is specifically linked to a known drug therapy. This linkage could be important inthe therapeutic application and clinical outcome of a drug, such as with personalized medicinefor oncology patients. The molecular diagnostics field plays a vital part in personalized medicineand has greatly expanded over the past twenty years, expanding by more than 20% annuallycompared to most other laboratory procedures. Research will continue to produce an increasedunderstanding of disease processes, and diagnostics manufacturers will continue to expand andrefine the technology and automation needed for clinical testing. Companion diagnostics,although smaller at present, is one of the fastest growing segments in the in vitro diagnostic(IVD) market. And while the concept of a drug-diagnostic combination is not new, it has onlyrecently started to generate interest with the move of healthcare towards pharmacogenomics.This TriMark Publications report examines the use of companion diagnostics in personalizedmedicine and cancer therapy. The study provides a qualitative and quantitative review of theindustry, including cancer biomarker tests, pharmacogenomics tests, recurrence predictiontests, blood-based technologies, proteomics and regulatory trends. Moreover, this analysisprofiles the leading companies that are developing and manufacturing companion diagnosticssolutions. Each company is discussed in extensive depth with a section on its history, productline, business and marketing analysis, and a subjective commentary of the companys marketposition. Detailed tables and charts with sales forecasts and market share data are also included.Table of Contents :1. Overview 9
  2. 2. 1.1 Statement of Report 91.2 About This Report 91.3 Scope of the Report 101.4 Objectives 111.5 Methodology 111.6 Executive Summary 132. Companion Diagnostics and Personalized Medicine 172.1 Scope of This Section 172.2 Introduction to Companion Diagnostics and Personalized Medicine 172.3 Drug Metabolism, Companion Diagnostics and Personalized Medicine 222.4 Examples of Personalized Medicine and Companion Diagnostic Tests 262.5 Personalized Medicine and Companion Diagnostic Testing Product Pipeline 292.6 The Personalized Medicine Coalition (PMC) 312.7 Regulatory Trends and Guidelines in the Personalized Medicine Space 382.7.1 The Changing Regulatory Landscape for Personalized Medicine 402.8 Companion Diagnostics Play an Increasing Role in Cancer Care 412.9 Specific Examples of Clinical Situations where Companion Diagnostics are being Deployed 422.9.1 Epidermal Growth Factor Receptor Assay 422.9.2 Individualized Warfarin Therapy 452.9.3 UGT1A1 Molecular Assay for Camptosar 462.9.4 Response to Gleevec in Gastrointestinal Stromal Tumors (GISTs) 462.9.5 LabCorp, ARCA Personalized Medicine Deal for Cardiovascular Diseases 462.9.6 Osmetech Licenses Epidauros Biotechnologie AG CYP2D6 Biomarker to Enter CompanionDiagnostics 472.9.7 Roche’s Metastatic Melanoma Treatment, Zelboraf (vemurafenib) 47
  3. 3. 2.9.8 Abbott’s Late-Stage NSCLC Treatment, Xalkori (crizotinib) 472.10 Diagnostic Tests for Personalized Analysis of Cancer Therapy Effectiveness 472.11 Value Chain 482.12 Impact of Companion Diagnostics/Personalized Medicine on Drug Clinical Trials 503. Companion Diagnostics: Qualitative and Quantitative Market Analysis 513.1 Market Analysis of Molecular Diagnostics and Companion Diagnostics 513.2 Costs of Companion Diagnostics in Healthcare Expenditures 523.3 Molecular Diagnostic Market 533.4 Molecular Diagnostics Technology Platforms and Their Impact on Clinical Medicine 553.5 Snapshot of Companion Diagnostics Industry Structure 573.6 The Case for Theranostics 583.7 Companion Diagnostics Market Analysis—Market Survey Data Characterizing the Qualitativeand Quantitative Industry Parameters 59For more information please visit link:http://www.aarkstore.com/reports/Companion-Diagnostics-in-Personalized-Medicine-and-Cancer-Therapy-185560.htmlNeelAarkstore EnterprisePhone:08149852585Email:enquiry@aarkstore.comURL:www.aarkstore.comhttp://www.facebook.com/aarkstoreenterprisehttp://in.linkedin.com/in/aarkstore
  4. 4. Breast Cancer Therapies Markets HIV-AIDS Testing Markets Over-the-Counter Diagnostic Products World Markets DNA Sequencing and PCR Markets Medical Imaging Markets Clinical Laboratory Testing Volume 2: Key Players for Laboratory Testing, BusinessTrends and Strategies Clinical Laboratory Testing Volume 1: IVD Reagents and Instruments Markets Diabetes, Metabolic Syndrome and Cardiovascular Disease Catheter Markets Blood Glucose Testing and Diabetes Management Global Flow Cytometry Market U.S. Glucose Testing Markets High-Growth Diagnostic Testing Markets European Point of Care Diagnostic Testing Markets Disposable Syringe Markets Point of Care Diagnostic Testing World Markets Disposable Medical Supplies Markets Molecular Diagnostics in Infectious Disease Testing Companion Diagnostics in Personalized Medicine and Cancer Therapy World Glucose Self-Testing Markets Veterinary Health Markets Point of Care Diagnostic Testing Sector Trends Cardiac Marker Diagnostic Testing Markets Mass Spectroscopy for Clinical Laboratory Analysis Cardiac Rhythm Management Devices World Markets Picture Archiving and Communications Systems (PACS) Biomarker Technology Platforms for Cancer Diagnoses and Therapies Cancer Diagnostic Testing World Markets Positron Emission Tomography (PET) Markets Molecular Diagnostics Markets Molecular Diagnostics in Cancer Testing Drugs of Abuse Testing Markets Ultrasound Markets
  5. 5. Nuclear Cardiology MarketsMedical Imaging BundleCancer Vaccines MarketsEuropean Medical Imaging MarketsRespiratory Therapeutics and Devices MarketsDiagnostics BundleMammography World MarketsIndias In Vitro Diagnostic Testing IndustryOrthopedics MarketsCell-Based Assays for Drug DiscoveryCytology and HPV Testing World MarketsClinical Chemistry AnalyzersClinical Immunoanalyzer MarketsMicroscopy MarketsAutomated Microbial Testing MarketsAnti-Infective Drugs MarketsPlastic Surgery Markets

×